Results for: antiepileptic
Two people living with epilepsy, Brianna Stanfield and George Nickell, talk about how the disorder has affected their lives. The two are currently enrolled in a clinical study of an investigational medication for people who experience frequent partial-onset seizures, despite taking antiepileptic medications. Information about the study is on www.EpilepsyClinicalTrial****.
*******www***rysstory**** This article describes some of the ways that canine epilepsy can be treated. You'll learn that there are things you can do to help make your dog comfortable and recover faster from seizures.
Welcome to Medico Remedies Pvt Ltd. ( *******www.medicoremediesindia**** ), manufacturer & exporter of pharmaceutical formulations. Established in 1994, at Mumbai, we are ISO 9001:2000 certified and are approved by WHO-GMP, CGMP& FDA. We are known for Ultra modern manufacturing plants. We are supported by a very well qualified and competent technical staff specializing in R & D and in new product development. Our product range includes Injectable, Syrups, Ointment, Oral Suspension and Capsules. We offer Atropin, Cefotaxine and Gentamicin Injection under Injectable that are easily accepted by the body without any side-effects. Our ointments are highly effective and easily absorbed by the skin and an easy solution for those who are unable to consume tablets and capsules. Vitamin B Complex, Biseptol M, Citadine 2 and Albamed Syrup under Syrups are highly effective. Along with that we offer Ampicillin, Cephalexin and Cephadroxyl under oral suspension. Anti-Infectives, Anti-ulcer Drugs, Vitamins, B-Lactum, Combination Drug Kits & other supplements under Tablets and Capsules are widely appreciated in Market. For more information please visit our website – *******www.medicoremediesindia****
The Epilepsy Foundation announced findings today that show people with epilepsy, whose seizures have been controlled with a consistent drug therapy, have a greater chance of increased seizures, greater side effects or sudden death when their medications are switched from one version of an antiepileptic drug (AED) to another, whether the switch was brand-to-generic, generic-to-brand or generic-to-generic.
The study, which surveyed more than 1,000 people with epilepsy, reveals that seizures worsened for 59 percent of people who had switched from a brand-name to a generic AED, while side effects increased for 49 percent of that same group. Additionally, seizures worsened for 15 percent of those who had switched from a generic to brand AED, while side effects increased for 18 percent of that same group. Furthermore, more than 25 percent of respondents reported experiencing problems after switching between different generic formulations of an AED.
To highlight the concerns raised in recent studies, the Epilepsy Foundation is filing a Citizen's Petition with the FDA, has sent alerts to neurologists and pharmacists across the country, and developed a Web site (www.epilepsyfoundation****/medicationswitching) to empower patients with information and the ability to share their experiences with medication switching.
Produced for Epilepsy Foundation of America